Uncategorized

Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry

The “Patent Expiration Cliff” Isn’t a Cliff—It’s a Calendar. Here’s How Commercial Market Access Teams Can Monetize the Window Before Generics Arrive.
If you’ve ever watched a branded product’s trajectory change overnight—rebates renegotiated, formular…

Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry Read Post »

Uncategorized

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Generic competition doesn’t just change prices—it redraws the map of who gets paid.
That’s the real story behind Paragraph IV challenges and pay-for-delay settlements: not “patent wars” as a headline, but a high-stakes transfer of value that can dete…

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked Read Post »

Biotechblog
Scroll to Top